Accessibility Menu
Doximity logo

Doximity(NYSE) DOCS

Market Cap$4.93BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-61%
5 Year-48%
1 Year-53%
1 Month+26%
$27.33
+32.29%
+6.67Today
After hours$27.82+$0.49 (+1.79%)
Doximity last closing stock price
MetricPriceDate
Last closeUSD 27.402026-08-07
Doximity stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+31.04%USD 20.912026-07-31
1 month+26.33%USD 21.692026-07-08
3 month+5.47%USD 25.982026-05-08
Year to date-38.12%USD 44.282025-12-31
1 year-53.2%USD 58.552025-08-07
3 year-16.44%USD 32.792023-08-08
5 year-47.67%USD 52.362021-08-06
Since inception-61.02%USD 53.002021-06-24

Doximity Financials at a Glance

Market Cap

$4.93BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$655.57M

Net Income (TTM)

$167.05M

EPS (TTM)

$0.84

P/E Ratio

32.49

Dividend

$0.00

Beta (Volatility)

1.41 (Average)

Price

$27.33

Volume

65,315,795

Open

$38.87

Previous Close

$27.40

Daily Range

$27.16 - $40.00

52-Week Range

$17.15 - $76.51

Estimated Earnings Date

Aug 6, 2026

DOCS: Motley Fool Moneyball Superscore

64

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Doximity

Doximity helps doctors and medical professionals talk to each other and care for patients online. The company makes tools for mobile phones and computers that simplify paperwork and medical scheduling. These digital services help pharmaceutical firms and hospitals reach healthcare experts across the United States.

What Doximity Builds

  • Marketing Solutions: Digital tools that let pharmaceutical companies and health systems share medical news and research with specific healthcare professionals.
  • Hiring Solutions: A professional database that helps medical recruiters find, message, and hire doctors or other clinical staff.
  • Workflow Solutions: Software for secure voice and video patient calls, digital faxing, and AI-driven writing help for clinical notes.

Recent Strategic Moves

  • Acquired Pathway Medical on July 29, 2025, to add artificial intelligence tools and new engineering talent to the platform.
  • Authorized a new program on February 3, 2026, to buy back up to $500 million of its own Class A common stock.
  • Purchased and retired over 8.6 million shares for $417 million under a previous buyback plan as of December 31, 2025.
  • Integrated an artificial intelligence writing assistant into the platform to help clinicians with administrative tasks and decision support.

What Makes the Platform Unique

Doximity operates as a specialized social network exclusively for the medical community, combining professional networking with clinical productivity tools. Its platform serves a dual purpose by helping doctors manage their daily work while providing a verified channel for healthcare companies to reach them.

The Financial Scorecard

  • Revenue grew to $185.1 million in Q3 2026, an increase of 9.8% from the previous year.
  • Net income was $61.6 million in Q3 2026, down 18.1% from $75.2 million in Q3 2025.
  • Free cash flow reached $62.9 million in Q3 2026, a slight decrease of 0.9% year-over-year.
  • Gross profit for the third quarter of 2026 was $166.4 million, representing a 7.7% increase from 2025.
  • Operating income hit $71.9 million in Q3 2026, down 10% from $79.9 million in the prior year period.

Bottom Line

Doximity has transitioned from a basic networking site into a multi-functional digital hub for the American medical workforce. By adding artificial intelligence and telehealth tools, the company has deepened its role in both clinical workflows and pharmaceutical marketing.

AI Generated • Apr 23, 2026

Industry

Health Care Technology

Employees

880

CEO

Jeffrey A. Tangney, MBA

Headquarters

San Francisco, CA 94107, US

DOCS Financials

Key Financial Metrics (TTM)

Gross Margin

88.07%

Operating Margin

29.60%

Net Income Margin

25.48%

Return on Equity

16.95%

Return on Capital

22.36%

Return on Assets

15.41%

Earnings Yield

3.08%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.93BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

179.75M

Volume

65.32M

Avg. Volume

5.40M

Financials (TTM)

Gross Profit

$577.34M

Operating Income

$194.05M

EBITDA

$243.80M

Operating Cash Flow

$306.34M

Capital Expenditure

-$7.06M

Free Cash Flow

$299.29M

Cash & ST Invst.

$687.79M

Total Debt

$9.67M

Doximity Performance Analysis

Doximity annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31USD 419,052,00022.0%
20242024-03-31USD 475,422,00013.5%
20252025-03-31USD 570,399,00020.0%
20262026-03-31USD 644,863,00013.1%
Doximity sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-3015.5%
Q32025-12-319.8%
Q42026-03-31-21.4%
Q12026-06-307.7%
Doximity annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31USD 0.53-24.1%
20242024-03-31USD 0.7235.7%
20252025-03-31USD 1.1154.6%
20262026-03-31USD 0.98-11.2%
Doximity sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-3014.8%
Q32025-12-31N/A
Q42026-03-31-67.7%
Q12026-06-3030.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2027YOY CHG

Revenue

$156.62M

+7.3%

Gross Profit

$132.93M

+2.2%

Gross Margin

84.87%

N/A

Market Cap

$4.93BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$5.60M

N/A

Employees

880

N/A

Net Income

$24.32M

-54.4%

EBITDA

$44.65M

-33.3%

Quarterly Fundamentals

Name
Q1 2027YOY CHG

Total Cash

$687.79M

-18.2%

Total Debt

$9.67M

-18.3%

Accounts Receivable

$177.58M

+25.4%

Inventory

$0.00

N/A

Long Term Debt

$7.53M

-22.1%

Short Term Debt

$2.14M

-1.2%

Return on Assets

15.41%

N/A

Return on Invested Capital

20.79%

N/A

Free Cash Flow

$41.93M

-30.3%

Operating Cash Flow

$41.99M

-32.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HQYHealthEquity, Inc.
$104.63+1.15%
TEMTempus AI, Inc.
$52.05+12.86%
EHCEncompass Health Corporation
$125.23+0.33%
ICLRICON Public Limited Company
$164.51+2.07%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$133.11+0.16%
TTDThe Trade Desk
$13.80-0.22%
NVDANvidia
$223.96+0.02%
TLTiShares Trust - iShares 20+ Year Treasury Bond ETF
$82.76+0.00%

Questions About DOCS

What is the current price of Doximity?

Doximity is trading at $27.40 per share.

What is the 52-week range for Doximity?

Over the past 52 weeks, Doximity has traded between $17.15 and $76.51.

How much debt does Doximity have?

As of the most recent reporting period, Doximity reported total debt of $10.19M.

How much cash does Doximity have on hand?

Doximity reported $219.18M in cash and cash equivalents in its most recent financial results.

What is Doximity’s dividend yield?

Doximity does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.